60 Degrees Pharmaceuticals, Inc. (SXTP)
1.08
-0.05
(-4.42%)
USD |
NASDAQ |
Aug 24, 16:00
1.09
+0.01
(+0.93%)
After-Hours: 20:00
60 Degrees Pharmaceuticals Total Liabilities (Quarterly) : 1.754M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.754M |
| March 31, 2026 | 2.019M |
| December 31, 2025 | 2.032M |
| September 30, 2025 | 2.342M |
| June 30, 2025 | 1.836M |
| March 31, 2025 | 1.949M |
| December 31, 2024 | 1.873M |
| September 30, 2024 | 1.458M |
| June 30, 2024 | 1.368M |
| March 31, 2024 | 1.254M |
| Date | Value |
|---|---|
| December 31, 2023 | 3.684M |
| September 30, 2023 | 2.634M |
| June 30, 2023 | 30.24M |
| March 31, 2023 | 27.12M |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 19.55M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Harrow, Inc. | 401.97M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 116.09B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.283M |
| Shareholders Equity (Quarterly) | 2.614M |
| Debt to Equity Ratio | 0.0578 |
| Current Ratio | 2.325 |
| Net Debt Paydown Yield | 0.02% |